Biotech companies provide the medical innovations and technological breakthroughs that improve healthcare and can achieve tremendous financial results in the process. However, these names also tend to be highly volatile as a result of the difficult and complex process associated with drug and medical device development as well as the hard-to-navigate regulatory environment. Still, investors look to companies with strong pipelines or exciting projects in progress for a hint about which biotech names may stand out in the months or quarters to come.
Two biotech names in particular—Axsome Therapeutics Inc. (NASDAQ: AXSM) and Innoviva Inc. (NASDAQ: INVA)—may draw particular attention from investors at the start of 2026. Each of these companies has potentially transformational products in various stages of development. Although nothing is guaranteed, these standouts might be worth watching this year.
